1. Home
  2. NGL vs TYRA Comparison

NGL vs TYRA Comparison

Compare NGL & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NGL ENERGY PARTNERS LP

NGL

NGL ENERGY PARTNERS LP

HOLD

Current Price

$11.57

Market Cap

1.4B

Sector

Utilities

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$37.73

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGL
TYRA
Founded
1940
2018
Country
United States
United States
Employees
569
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NGL
TYRA
Price
$11.57
$37.73
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$44.63
AVG Volume (30 Days)
230.3K
1.1M
Earning Date
02-03-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$366.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.64
$6.42
52 Week High
$13.00
$38.53

Technical Indicators

Market Signals
Indicator
NGL
TYRA
Relative Strength Index (RSI) 50.19 68.00
Support Level $11.18 $30.10
Resistance Level $13.00 N/A
Average True Range (ATR) 0.53 2.31
MACD -0.08 0.24
Stochastic Oscillator 31.75 92.17

Price Performance

Historical Comparison
NGL
TYRA

About NGL NGL ENERGY PARTNERS LP

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: